The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling.
Identifieur interne : 000240 ( PubMed/Checkpoint ); précédent : 000239; suivant : 000241The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling.
Auteurs : Rocío Davi A Nú Ez [Allemagne] ; Matthias Budt [Allemagne] ; Sandra Saenger [Allemagne] ; Katharina Paki [Allemagne] ; Ulrike Arnold [Allemagne] ; Anne Sadewasser [Allemagne] ; Thorsten Wolff [Allemagne]Source :
- International journal of molecular sciences [ 1422-0067 ] ; 2018.
Descripteurs français
- KwdFr :
- ARN viral (métabolisme), Antiviraux (métabolisme), Cellules A549, Cellules HeLa, DEAD-box RNA helicases (métabolisme), Domaines protéiques, Granulations cytoplasmiques (métabolisme), Humains, Interféron bêta (génétique), Interféron bêta (métabolisme), Liaison aux protéines, Protéine-58 à domaine DEAD (), Protéine-58 à domaine DEAD (métabolisme), Protéines proto-oncogènes (métabolisme), Régulation de l'expression des gènes, Transduction du signal, Transport de protéines.
- MESH :
- génétique : Interféron bêta.
- métabolisme : ARN viral, Antiviraux, DEAD-box RNA helicases, Granulations cytoplasmiques, Interféron bêta, Protéine-58 à domaine DEAD, Protéines proto-oncogènes.
- Cellules A549, Cellules HeLa, Domaines protéiques, Humains, Liaison aux protéines, Protéine-58 à domaine DEAD, Régulation de l'expression des gènes, Transduction du signal, Transport de protéines.
English descriptors
- KwdEn :
- A549 Cells, Antiviral Agents (metabolism), Cytoplasmic Granules (metabolism), DEAD Box Protein 58 (chemistry), DEAD Box Protein 58 (metabolism), DEAD-box RNA Helicases (metabolism), Gene Expression Regulation, HeLa Cells, Humans, Interferon-beta (genetics), Interferon-beta (metabolism), Protein Binding, Protein Domains, Protein Transport, Proto-Oncogene Proteins (metabolism), RNA, Viral (metabolism), Signal Transduction.
- MESH :
- chemical , chemistry : DEAD Box Protein 58.
- chemical , genetics : Interferon-beta.
- chemical , metabolism : Antiviral Agents, DEAD Box Protein 58, DEAD-box RNA Helicases, Interferon-beta, Proto-Oncogene Proteins, RNA, Viral.
- metabolism : Cytoplasmic Granules.
- A549 Cells, Gene Expression Regulation, HeLa Cells, Humans, Protein Binding, Protein Domains, Protein Transport, Signal Transduction.
Abstract
Virus infections induce sensitive antiviral responses within the host cell. The RNA helicase retinoic acid-inducible gene I (RIG-I) is a key sensor of influenza virus RNA that induces the expression of antiviral type I interferons. Recent evidence suggests a complex pattern of RIG-I regulation involving multiple interactions and cellular sites. In an approach employing affinity purification and quantitative mass spectrometry, we identified proteins with increased binding to RIG-I in response to influenza B virus infection. Among them was the RIG-I related RNA helicase DEAD box helicase 6 (DDX6), a known component of cytoplasmic mRNA-ribonucleoprotein (mRNP) granules like P-bodies and stress granules (SGs). RIG-I and DDX6 both localized to the cytosol and were detected in virus-induced SGs. Coimmunoprecipitation assays detected a basal level of complexes harboring RIG-I and DDX6 that increased after infection. Functionally, DDX6 augmented RIG-I mediated induction of interferon (IFN)-β expression. Notably, DDX6 was found to bind viral RNA capable to stimulate RIG-I. These findings imply a novel function for DDX6 as an RNA co-sensor and signaling enhancer for RIG-I.
DOI: 10.3390/ijms19071877
PubMed: 29949917
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:29949917Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling.</title>
<author><name sortKey="Nu Ez, Rocio Davi A" sort="Nu Ez, Rocio Davi A" uniqKey="Nu Ez R" first="Rocío Davi A" last="Nú Ez">Rocío Davi A Nú Ez</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. rociodavinha@outlook.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Budt, Matthias" sort="Budt, Matthias" uniqKey="Budt M" first="Matthias" last="Budt">Matthias Budt</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. budtm@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Saenger, Sandra" sort="Saenger, Sandra" uniqKey="Saenger S" first="Sandra" last="Saenger">Sandra Saenger</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. saengers@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Paki, Katharina" sort="Paki, Katharina" uniqKey="Paki K" first="Katharina" last="Paki">Katharina Paki</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. katharina.paki@boehringer-ingelheim.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arnold, Ulrike" sort="Arnold, Ulrike" uniqKey="Arnold U" first="Ulrike" last="Arnold">Ulrike Arnold</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. arnoldu@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sadewasser, Anne" sort="Sadewasser, Anne" uniqKey="Sadewasser A" first="Anne" last="Sadewasser">Anne Sadewasser</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. anne.sadewasser@secarna.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wolff, Thorsten" sort="Wolff, Thorsten" uniqKey="Wolff T" first="Thorsten" last="Wolff">Thorsten Wolff</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. wolfft@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29949917</idno>
<idno type="pmid">29949917</idno>
<idno type="doi">10.3390/ijms19071877</idno>
<idno type="wicri:Area/PubMed/Corpus">000258</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000258</idno>
<idno type="wicri:Area/PubMed/Curation">000258</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000258</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000240</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000240</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling.</title>
<author><name sortKey="Nu Ez, Rocio Davi A" sort="Nu Ez, Rocio Davi A" uniqKey="Nu Ez R" first="Rocío Davi A" last="Nú Ez">Rocío Davi A Nú Ez</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. rociodavinha@outlook.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Budt, Matthias" sort="Budt, Matthias" uniqKey="Budt M" first="Matthias" last="Budt">Matthias Budt</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. budtm@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Saenger, Sandra" sort="Saenger, Sandra" uniqKey="Saenger S" first="Sandra" last="Saenger">Sandra Saenger</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. saengers@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Paki, Katharina" sort="Paki, Katharina" uniqKey="Paki K" first="Katharina" last="Paki">Katharina Paki</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. katharina.paki@boehringer-ingelheim.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arnold, Ulrike" sort="Arnold, Ulrike" uniqKey="Arnold U" first="Ulrike" last="Arnold">Ulrike Arnold</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. arnoldu@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sadewasser, Anne" sort="Sadewasser, Anne" uniqKey="Sadewasser A" first="Anne" last="Sadewasser">Anne Sadewasser</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. anne.sadewasser@secarna.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wolff, Thorsten" sort="Wolff, Thorsten" uniqKey="Wolff T" first="Thorsten" last="Wolff">Thorsten Wolff</name>
<affiliation wicri:level="3"><nlm:affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. wolfft@rki.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of molecular sciences</title>
<idno type="eISSN">1422-0067</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>A549 Cells</term>
<term>Antiviral Agents (metabolism)</term>
<term>Cytoplasmic Granules (metabolism)</term>
<term>DEAD Box Protein 58 (chemistry)</term>
<term>DEAD Box Protein 58 (metabolism)</term>
<term>DEAD-box RNA Helicases (metabolism)</term>
<term>Gene Expression Regulation</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Interferon-beta (genetics)</term>
<term>Interferon-beta (metabolism)</term>
<term>Protein Binding</term>
<term>Protein Domains</term>
<term>Protein Transport</term>
<term>Proto-Oncogene Proteins (metabolism)</term>
<term>RNA, Viral (metabolism)</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (métabolisme)</term>
<term>Antiviraux (métabolisme)</term>
<term>Cellules A549</term>
<term>Cellules HeLa</term>
<term>DEAD-box RNA helicases (métabolisme)</term>
<term>Domaines protéiques</term>
<term>Granulations cytoplasmiques (métabolisme)</term>
<term>Humains</term>
<term>Interféron bêta (génétique)</term>
<term>Interféron bêta (métabolisme)</term>
<term>Liaison aux protéines</term>
<term>Protéine-58 à domaine DEAD ()</term>
<term>Protéine-58 à domaine DEAD (métabolisme)</term>
<term>Protéines proto-oncogènes (métabolisme)</term>
<term>Régulation de l'expression des gènes</term>
<term>Transduction du signal</term>
<term>Transport de protéines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DEAD Box Protein 58</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Interferon-beta</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antiviral Agents</term>
<term>DEAD Box Protein 58</term>
<term>DEAD-box RNA Helicases</term>
<term>Interferon-beta</term>
<term>Proto-Oncogene Proteins</term>
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Interféron bêta</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cytoplasmic Granules</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>ARN viral</term>
<term>Antiviraux</term>
<term>DEAD-box RNA helicases</term>
<term>Granulations cytoplasmiques</term>
<term>Interféron bêta</term>
<term>Protéine-58 à domaine DEAD</term>
<term>Protéines proto-oncogènes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>A549 Cells</term>
<term>Gene Expression Regulation</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Protein Binding</term>
<term>Protein Domains</term>
<term>Protein Transport</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cellules A549</term>
<term>Cellules HeLa</term>
<term>Domaines protéiques</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Protéine-58 à domaine DEAD</term>
<term>Régulation de l'expression des gènes</term>
<term>Transduction du signal</term>
<term>Transport de protéines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Virus infections induce sensitive antiviral responses within the host cell. The RNA helicase retinoic acid-inducible gene I (RIG-I) is a key sensor of influenza virus RNA that induces the expression of antiviral type I interferons. Recent evidence suggests a complex pattern of RIG-I regulation involving multiple interactions and cellular sites. In an approach employing affinity purification and quantitative mass spectrometry, we identified proteins with increased binding to RIG-I in response to influenza B virus infection. Among them was the RIG-I related RNA helicase DEAD box helicase 6 (DDX6), a known component of cytoplasmic mRNA-ribonucleoprotein (mRNP) granules like P-bodies and stress granules (SGs). RIG-I and DDX6 both localized to the cytosol and were detected in virus-induced SGs. Coimmunoprecipitation assays detected a basal level of complexes harboring RIG-I and DDX6 that increased after infection. Functionally, DDX6 augmented RIG-I mediated induction of interferon (IFN)-β expression. Notably, DDX6 was found to bind viral RNA capable to stimulate RIG-I. These findings imply a novel function for DDX6 as an RNA co-sensor and signaling enhancer for RIG-I.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29949917</PMID>
<DateCompleted><Year>2018</Year>
<Month>10</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>19</Volume>
<Issue>7</Issue>
<PubDate><Year>2018</Year>
<Month>06</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>International journal of molecular sciences</Title>
<ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E1877</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms19071877</ELocationID>
<Abstract><AbstractText>Virus infections induce sensitive antiviral responses within the host cell. The RNA helicase retinoic acid-inducible gene I (RIG-I) is a key sensor of influenza virus RNA that induces the expression of antiviral type I interferons. Recent evidence suggests a complex pattern of RIG-I regulation involving multiple interactions and cellular sites. In an approach employing affinity purification and quantitative mass spectrometry, we identified proteins with increased binding to RIG-I in response to influenza B virus infection. Among them was the RIG-I related RNA helicase DEAD box helicase 6 (DDX6), a known component of cytoplasmic mRNA-ribonucleoprotein (mRNP) granules like P-bodies and stress granules (SGs). RIG-I and DDX6 both localized to the cytosol and were detected in virus-induced SGs. Coimmunoprecipitation assays detected a basal level of complexes harboring RIG-I and DDX6 that increased after infection. Functionally, DDX6 augmented RIG-I mediated induction of interferon (IFN)-β expression. Notably, DDX6 was found to bind viral RNA capable to stimulate RIG-I. These findings imply a novel function for DDX6 as an RNA co-sensor and signaling enhancer for RIG-I.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Núñez</LastName>
<ForeName>Rocío Daviña</ForeName>
<Initials>RD</Initials>
<Identifier Source="ORCID">0000-0003-4232-7100</Identifier>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. rociodavinha@outlook.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Budt</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. budtm@rki.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saenger</LastName>
<ForeName>Sandra</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. saengers@rki.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Paki</LastName>
<ForeName>Katharina</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. katharina.paki@boehringer-ingelheim.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arnold</LastName>
<ForeName>Ulrike</ForeName>
<Initials>U</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. arnoldu@rki.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sadewasser</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. anne.sadewasser@secarna.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wolff</LastName>
<ForeName>Thorsten</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Robert Koch-Institut, FG17-Division of Influenza Viruses and other Respiratory Viruses, 13353 Berlin, Germany. wolfft@rki.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>06</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Int J Mol Sci</MedlineTA>
<NlmUniqueID>101092791</NlmUniqueID>
<ISSNLinking>1422-0067</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>77238-31-4</RegistryNumber>
<NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="C452820">DDX58 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="C094683">DDX6 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber>
<NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber>
<NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003594" MajorTopicYN="N">Cytoplasmic Granules</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">DDX6</Keyword>
<Keyword MajorTopicYN="Y">RIG-I</Keyword>
<Keyword MajorTopicYN="Y">influenza</Keyword>
<Keyword MajorTopicYN="Y">interferon</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>12</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2018</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>06</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>10</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29949917</ArticleId>
<ArticleId IdType="pii">ijms19071877</ArticleId>
<ArticleId IdType="doi">10.3390/ijms19071877</ArticleId>
<ArticleId IdType="pmc">PMC6073104</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Oncogene. 2014 Mar 20;33(12):1515-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23584477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2011 Apr 21;9(4):299-309</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21501829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2011 Sep;31(18):3802-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21791617</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Dec;86(23):12695-707</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22973032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Immunol. 2014 Sep;35(9):420-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25153707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wiley Interdiscip Rev RNA. 2014 Sep-Oct;5(5):659-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24788243</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2012 Apr;26(4):1629-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22202676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2013;9(8):e1003533</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23950712</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2009 Aug 7;138(3):576-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19631370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Feb;86(3):1358-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22114345</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes Cells. 2006 Apr;11(4):439-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16611246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11770-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22745163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2016 Jan 20;90(7):3661-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26792746</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2005 May;5(5):375-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15864272</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(2):e56659</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23451066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2017 Feb 2;65(3):403-415.e8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28132841</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2009 Oct;10(10):1065-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19609254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2006 Sep;25(3):349-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16979567</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2014 Apr 9;15(4):484-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24721576</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2012 Sep;18(9):1702-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22836354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2010 Apr 16;141(2):315-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20403326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunobiology. 2013 Nov;218(11):1322-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23896194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 Jan;10(1):e1003848</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24391503</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Dec;80(23):11667-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16987984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Nov 10;314(5801):997-1001</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17038589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Sep;88(18):10432-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24942585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Feb;78(4):1865-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14747551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2006 May 4;441(7089):101-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2013 Feb 20;436(2):255-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23290869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2006 Jul;4(7):e210</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16756390</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2015 Nov 15;90:57-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25896634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Nov 10;314(5801):994-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17038590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jan;81(2):514-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17079289</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Immunol. 2015 Feb;32:48-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25594890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Cell Mol Biol. 2007 Mar;36(3):263-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17053203</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2017 May 04;8:15138</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28469175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Rep. 2017 Nov 7;21(6):1613-1623</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29117565</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2012;8(11):e1003059</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23209422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5646-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24706898</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(21):11574-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15479798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2014 Jun 5;54(5):737-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24768540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2009 May 8;5(5):439-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19454348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2012 May 17;11(5):528-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22607805</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2015 Oct 1;60(1):118-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26412305</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Rep. 2017 Jul 25;20(4):819-831</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28746868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2014 May 1;509(7498):110-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24590070</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Jan;85(2):1036-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21068236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Dec;89(23):12014-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26378160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 Jul 10;10(7):e1004217</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25010204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Mol Biol Transl Sci. 2009;90:155-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20374741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Apr 28;472(7344):481-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21478870</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 Mar 20;10(3):e1004012</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24651521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Cell Infect Microbiol. 2017 Aug 04;7:356</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28824886</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2017 Jan 3;91(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27807226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2014 Jun 19;40(6):936-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24931123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Interferon Cytokine Res. 2011 Jan;31(1):59-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21166592</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(8):e43031</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22912779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2015 Mar 11;17(3):309-319</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25704008</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Sep 25;479(7373):423-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21947008</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):596-601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26733676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2011 Jan;12(1):37-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21102435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Microbiol. 2007 Apr;9(4):930-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17140406</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA Biol. 2011 Nov-Dec;8(6):1173-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21957497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2013 Mar 21;38(3):437-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23499489</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Berlin</li>
</region>
<settlement><li>Berlin</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Berlin"><name sortKey="Nu Ez, Rocio Davi A" sort="Nu Ez, Rocio Davi A" uniqKey="Nu Ez R" first="Rocío Davi A" last="Nú Ez">Rocío Davi A Nú Ez</name>
</region>
<name sortKey="Arnold, Ulrike" sort="Arnold, Ulrike" uniqKey="Arnold U" first="Ulrike" last="Arnold">Ulrike Arnold</name>
<name sortKey="Budt, Matthias" sort="Budt, Matthias" uniqKey="Budt M" first="Matthias" last="Budt">Matthias Budt</name>
<name sortKey="Paki, Katharina" sort="Paki, Katharina" uniqKey="Paki K" first="Katharina" last="Paki">Katharina Paki</name>
<name sortKey="Sadewasser, Anne" sort="Sadewasser, Anne" uniqKey="Sadewasser A" first="Anne" last="Sadewasser">Anne Sadewasser</name>
<name sortKey="Saenger, Sandra" sort="Saenger, Sandra" uniqKey="Saenger S" first="Sandra" last="Saenger">Sandra Saenger</name>
<name sortKey="Wolff, Thorsten" sort="Wolff, Thorsten" uniqKey="Wolff T" first="Thorsten" last="Wolff">Thorsten Wolff</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000240 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000240 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:29949917 |texte= The RNA Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:29949917" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
This area was generated with Dilib version V0.6.33. |